Literature DB >> 2462928

Mechanism of cryoprotection by extracellular polymeric solutes.

T Takahashi1, A Hirsh, E Erbe, R J Williams.   

Abstract

To elucidate the means by which polymer solutions protect cells from freezing injury, we cooled human monocytes to -80 degrees C or below in the presence of various polymers. Differential scanning calorimetric studies showed that those polymers which protect cells best have a limiting glass transition temperature (T'g) of approximately -20 degrees C; those with a T'g significantly higher or lower did not protect. Freeze-etch electron micrographs indicated that intracellular ice crystals had formed during this freezing procedure, but remained smaller than approximately 300 nm in the same proportion of cells as survived rapid thawing. We propose that cryoprotection of slowly frozen monocytes by polymers is a consequence of a T'g of -20 degrees C in the extracellular solution. In our hypothesis, the initial concentration and viscosity of protective polymer solutions reduce the extent and rate of cell water loss to extracellular ice and limit the injurious osmotic stress, which cells face during freezing at moderate rates to -20 degrees C. Below -20 degrees C, glass formation prevents further osmotic stress by isolating cells from extracellular ice crystals, virtually eliminating cell water loss at lower temperatures. On the other hand, the protective polymer solutions will allow some diffusion of water away from cells at temperatures above T'g. If conditions are correct, cells will concentrate the cytoplasm sufficiently during the initial cooling to T'g to avoid lethal intracellular freezing between T'g and the intracellular Tg, which has been depressed to low temperatures by that concentration. Thus, when polymers are used as cryoprotective agents, cell survival is contingent upon maintenance of osmotic stress within narrow limits.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462928      PMCID: PMC1330349          DOI: 10.1016/S0006-3495(88)82983-7

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  17 in total

1.  The mechanism of the protective action of glycerol against haemolysis by freezing and thawing.

Authors:  J E LOVELOCK
Journal:  Biochim Biophys Acta       Date:  1953-05

2.  The haemolysis of human red blood-cells by freezing and thawing.

Authors:  J E LOVELOCK
Journal:  Biochim Biophys Acta       Date:  1953-03

3.  Assessment of blood leukocyte microbial killing by using a new fluorochrome microassay.

Authors:  C G Pantazis; W T Kniker
Journal:  J Reticuloendothel Soc       Date:  1979-08

4.  Serology for automated cytotoxicity assays. Contrast fluorescence test.

Authors:  J L Martel; S Jaramillo; F H Allen; P Rubinstein
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

5.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.

Authors:  R Snyderman; L C Altman; M S Hausman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

6.  A stable state of frozen protoplasm with invisible intracellular ice crystals obtained by rapid cooling.

Authors:  E Asahina; K Shimada; Y Hisada
Journal:  Exp Cell Res       Date:  1970-03       Impact factor: 3.905

7.  Is there a common mechanism of protection of living cells by polyvinylpyrrolidone and glycerol ding freezing?

Authors:  J Farrant
Journal:  Nature       Date:  1969-06-21       Impact factor: 49.962

8.  Calorimetric studies of the state of water in deeply frozen human monocytes.

Authors:  T Takahashi; A Hirsh
Journal:  Biophys J       Date:  1985-03       Impact factor: 4.033

9.  Differing actions of penetrating and nonpenetrating cryoprotective agents.

Authors:  L E McGann
Journal:  Cryobiology       Date:  1978-08       Impact factor: 2.487

10.  Optimal temperature ranges for control of cooling rate.

Authors:  L E McGann
Journal:  Cryobiology       Date:  1979-06       Impact factor: 2.487

View more
  8 in total

1.  Calorimetric determination of inhibition of ice crystal growth by antifreeze protein in hydroxyethyl starch solutions.

Authors:  T N Hansen; J F Carpenter
Journal:  Biophys J       Date:  1993-06       Impact factor: 4.033

2.  GMP cryopreservation of large volumes of cells for regenerative medicine: active control of the freezing process.

Authors:  Isobel Massie; Clare Selden; Humphrey Hodgson; Barry Fuller; Stephanie Gibbons; G John Morris
Journal:  Tissue Eng Part C Methods       Date:  2014-02-24       Impact factor: 3.056

3.  Principles of Ice-Free Cryopreservation by Vitrification.

Authors:  Gregory M Fahy; Brian Wowk
Journal:  Methods Mol Biol       Date:  2021

4.  Preservation of differentiation and clonogenic potential of human hematopoietic stem and progenitor cells during lyophilization and ambient storage.

Authors:  Sandhya S Buchanan; David W Pyatt; John F Carpenter
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

5.  Exploring the Possibility of Cryopreservation of Feline and Canine Erythrocytes by Rapid Freezing with Penetrating and Non-Penetrating Cryoprotectants.

Authors:  Denys Pogozhykh; Yuliya Pakhomova; Olga Pervushina; Nicola Hofmann; Birgit Glasmacher; Gennadiy Zhegunov
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

6.  Storage stability of liposomes stored at elevated subzero temperatures in DMSO/sucrose mixtures.

Authors:  Bulat Sydykov; Harriëtte Oldenhof; Harald Sieme; Willem F Wolkers
Journal:  PLoS One       Date:  2018-07-05       Impact factor: 3.240

Review 7.  Winter is coming: the future of cryopreservation.

Authors:  Sanja Bojic; Alex Murray; Roman Bauer; João Pedro de Magalhães; Barry L Bentley; Ralf Spindler; Piotr Pawlik; José L Cordeiro
Journal:  BMC Biol       Date:  2021-03-24       Impact factor: 7.431

8.  Along the Process Chain to Probiotic Tablets: Evaluation of Mechanical Impacts on Microbial Viability.

Authors:  Karl Vorländer; Ingo Kampen; Jan Henrik Finke; Arno Kwade
Journal:  Pharmaceutics       Date:  2020-01-15       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.